Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-08 Disposition | 2023-03-09 09:16 am | N/A 2031-03-09 | F-star Therapeutics Inc. | FSTX | Brewis Neil CHIEF SCIENTIFIC OFFICER | 229,293 | $0 | 0 (Direct) | View |
| 2023-03-08 Disposition | 2023-03-09 09:16 am | N/A N/A | F-star Therapeutics Inc. | FSTX | Brewis Neil CHIEF SCIENTIFIC OFFICER | 9,375 | $7.12 | 0 (Direct) | View |
| 2023-03-08 Equity Swap | 2023-03-09 09:16 am | N/A N/A | F-star Therapeutics Inc. | FSTX | Brewis Neil CHIEF SCIENTIFIC OFFICER | 105,088 | $7.12 | 0 (Direct) | View |
| 2022-07-29 Exercise | 2022-08-02 9:07 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 76,619 | $0.11 | 114,463 (Direct) | View |
| 2022-07-29 Exercise | 2022-08-02 9:07 pm | N/A 2029-05-07 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 76,619 | $0 | 114,463 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:02 pm | N/A 2032-03-31 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 132,469 | $0 | 132,469 (Direct) | View |
| 2022-01-09 Option Award | 2022-01-11 5:30 pm | N/A 2032-01-09 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 74,263 | $0 | 74,263 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-11 4:11 pm | N/A 2021-03-09 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 22,561 | $0 | 99,180 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-02 4:29 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 18,000 | $0 | 37,844 (Direct) | View |
| 2020-11-20 Option Award | 2020-11-24 7:00 pm | N/A 2029-05-07 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 96,463 | $0 | 96,463 (Direct) | View |